A prognostic model for Hodgkin's disease (HD) based on IL-10.

被引：0
|
作者：
Sarris, AH
Viviani, S
Bonfante, V
Kliche, KO
Notti, P
Peethambaram, P
Tucker, S
Preti, A
Mesina, O
Hagemeister, F
Romaguera, J
McLaughlin, P
Rodriguez, MA
Andreeff, M
Witzig, T
Bonadonna, J
Cabanillas, F
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Houston, TX 77030 USA
[2] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
[3] Ist Tumori, Milan, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
991
引用
收藏
页码：243A / 243A
页数：1
相关论文
共 50 条
  • [1] Relation between IL-10 and IL-12 secretion in Hodgkin's disease (HD)
    Viviani, S
    Notti, P
    Bonfante, V
    Camerini, E
    Parra, HS
    Santoro, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1225 - 1225
  • [2] Prognostic factors for advanced stage Hodgkin's disease (HD)
    Vassilakopoulos, TP
    Barbounis, A
    Angelopoulou, MK
    Boussiotis, VA
    Hatziioannou, M
    Kontopidou, F
    Fessas, P
    Kittas, C
    Pangalis, GA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 411 - 411
  • [3] Elevated serum IL-10: An adverse prognostic factor for failure-free survival (FFS) in adults with advanced Hodgkin's disease (HD).
    Sarris, AH
    Kliche, KO
    Smith, T
    Preti, A
    Messina, O
    Hess, M
    Pugh, W
    Andreeff, M
    Cabanillas, F
    [J]. BLOOD, 1996, 88 (10) : 894 - 894
  • [4] Cytogenetic results in Hodgkin's disease (HD)
    Falzetti, D
    Crescenzi, B
    Matteucci, C
    Falini, B
    Martelli, MF
    Mecucci, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1249 - 1249
  • [5] Fatigue in Hodgkin's disease (HD): Results from the GHSG multicentre trials HD10-12
    Flechtner, H.
    Brillant, C.
    Schober, T.
    Pfistner, B.
    Koch, B.
    Sieber, M. .
    Rueffer, U.
    Mueller, R. P.
    Mueller-Hermelink, R. P.
    Castiglione, M.
    Markova, J.
    Schlimok, G.
    Graf, T.
    Krause, J.
    Truemper, L.
    Meissner, P.
    Paulus, U.
    Wolf, J.
    Engert, A.
    Diehl, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 51 - 52
  • [6] Clinical significance of soluble IL-2 receptors (S-IL-2R) in Hodgkin's disease (HD)
    Viviani, S
    Devizzi, L
    Bonfante, V
    Camerini, E
    Santoro, A
    Fornier, M
    Valagussa, P
    Bonadonna, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 782 - 782
  • [7] Prognostic factors in Hodgkin's disease
    Provencio, M
    España, P
    Millán, I
    Yebra, M
    Sánchez, AC
    de la Torre, A
    Bonilla, F
    Regueiro, CA
    DE Letona, JML
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1133 - 1139
  • [8] Prognostic score for Hodgkin's disease
    Jack, FR
    Angus, B
    Taylor, PRA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16): : 1288 - 1289
  • [9] Gallium scan in adolescents and children with Hodgkin's disease (HD) - Treatment response assesment and prognostic value
    Castellani, MR
    Cefalo, G
    Terenziani, M
    Aliberti, G
    Maccauro, M
    Alessi, A
    Villano, C
    Bombardieri, E
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2003, 47 (01): : 22 - 30
  • [10] Quality of life (QL) in Hodgkin's disease (HD): Results from the GHSG multicentre trials HD10-12
    Flechtner, H.
    Brillant, C.
    Schober, T.
    Pfistner, B.
    Nisters-Backes, H.
    Sieber, M.
    Rueffer, U.
    Mueller, R. P.
    Mueller-Hermelink, H. K.
    Castiglione, M.
    Glunz, A.
    Greil, R.
    Brunch, J.
    Rank, A.
    Nogova, L.
    Kreibich, U.
    Paulus, U.
    Wolf, J.
    Engert, A.
    Diehl, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 51 - 51
12345